Loading…
Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy
Transthyretin amyloid neuropathy of type 1 (Swedish–Portuguese type) is an autosomally inherited progressive disease with a Val30Met mutation, causing generalized sensory‐motor polyneuropathy. Quantitative sensory testing (QST) quantifies thermal threshold changes in patients with manifest general p...
Saved in:
Published in: | Muscle & nerve 2007-02, Vol.35 (2), p.189-195 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23 |
---|---|
cites | cdi_FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23 |
container_end_page | 195 |
container_issue | 2 |
container_start_page | 189 |
container_title | Muscle & nerve |
container_volume | 35 |
creator | Heldestad, Victoria Nordh, Erik |
description | Transthyretin amyloid neuropathy of type 1 (Swedish–Portuguese type) is an autosomally inherited progressive disease with a Val30Met mutation, causing generalized sensory‐motor polyneuropathy. Quantitative sensory testing (QST) quantifies thermal threshold changes in patients with manifest general polyneuropathy, but its applicability at an early clinical stage of a strict biochemically defined disease has not yet been shown. Thermal QST was performed in 23 patients having a positive Val30Met marker and clinical symptoms of peripheral small‐fiber neuropathy but normal electrophysiological findings and compared to a reference group of 43 healthy volunteers, both subdivided into age groups ≤45 and >45 years. Significant differences between patients and controls were found at all test sites in both age groups, except for warm thresholds at the medial lower leg in those >45 years. QST thus demonstrated elevated thermal thresholds before the development of electrophysiological abnormalities, which indicate large‐fiber involvement. These findings confirm that QST is a useful method for documentation of developing polyneuropathy. Muscle Nerve, 2006 |
doi_str_mv | 10.1002/mus.20689 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_umu_10680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68945756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS1ERZfCgS-AcqESEmnHju0kx2rLLkhtEX8K3CzHmRRDEgc7oeTb4zZLe0KcZqT5vRn7PUKeUTiiAOy4m8IRA1mUD8iKQpmnXJTFQ7ICyotUZuXXffI4hO8AQAuZPyL7NIeSQ1msiHk_6X60jcU6CdgH5-dEV73znW7taDEktk9Q-3ZOrrDH0Rrdxv4X-kUzet2H8dvs46hPdDe3ztbJ4Nq5x8m7QcfZE7LX6Dbg0109IJeb15_Wb9Kzd9u365Oz1AgJZWryCkFUGdC65pQKyZqSZcY0WrCsYBQilVW8obxmjWQosTGcogHBs6quWXZAXi17wzUOU6UGbzvtZ-W0Vaf284ly_kpN3aRo9Aoifrjgg3c_Jwyj6mww2La6RzcFFf3kIhfyvyAtBQOWFxF8uYDGuxA8NndPoKBuklIxKXWbVGSf75ZOVYf1PbmLJgIvdoAO0fQmGm1suOcKQeMnROSOF-7atjj_-6I6v_z493S6KGwY8fedQvsfSuZZLtSXi63abtYb_mFzrk6zP0uNvE0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19520278</pqid></control><display><type>article</type><title>Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy</title><source>Wiley</source><creator>Heldestad, Victoria ; Nordh, Erik</creator><creatorcontrib>Heldestad, Victoria ; Nordh, Erik</creatorcontrib><description>Transthyretin amyloid neuropathy of type 1 (Swedish–Portuguese type) is an autosomally inherited progressive disease with a Val30Met mutation, causing generalized sensory‐motor polyneuropathy. Quantitative sensory testing (QST) quantifies thermal threshold changes in patients with manifest general polyneuropathy, but its applicability at an early clinical stage of a strict biochemically defined disease has not yet been shown. Thermal QST was performed in 23 patients having a positive Val30Met marker and clinical symptoms of peripheral small‐fiber neuropathy but normal electrophysiological findings and compared to a reference group of 43 healthy volunteers, both subdivided into age groups ≤45 and >45 years. Significant differences between patients and controls were found at all test sites in both age groups, except for warm thresholds at the medial lower leg in those >45 years. QST thus demonstrated elevated thermal thresholds before the development of electrophysiological abnormalities, which indicate large‐fiber involvement. These findings confirm that QST is a useful method for documentation of developing polyneuropathy. Muscle Nerve, 2006</description><identifier>ISSN: 0148-639X</identifier><identifier>ISSN: 1097-4598</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/mus.20689</identifier><identifier>PMID: 17094098</identifier><identifier>CODEN: MUNEDE</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Age Factors ; Amyloid Neuropathies - complications ; Amyloid Neuropathies - genetics ; Amyloid Neuropathies/complications/genetics ; amyloidosis ; Biological and medical sciences ; Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction ; Diseases of striated muscles. Neuromuscular diseases ; Female ; Humans ; Male ; Medical sciences ; Methionine - genetics ; Nervous system (semeiology, syndromes) ; Neurology ; Peripheral Nerves - physiopathology ; Prealbumin - genetics ; QST ; quantitative sensory testing ; Sensory Thresholds - physiology ; small-fiber neuropathy ; Somatosensory Disorders - etiology ; Somatosensory Disorders - genetics ; Somatosensory Disorders/etiology/genetics ; Temperature ; thermal thresholds ; transthyretin ; Valine - genetics</subject><ispartof>Muscle & nerve, 2007-02, Vol.35 (2), p.189-195</ispartof><rights>Copyright © 2006 Wiley Periodicals, Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23</citedby><cites>FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18518035$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17094098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-10680$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Heldestad, Victoria</creatorcontrib><creatorcontrib>Nordh, Erik</creatorcontrib><title>Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy</title><title>Muscle & nerve</title><addtitle>Muscle Nerve</addtitle><description>Transthyretin amyloid neuropathy of type 1 (Swedish–Portuguese type) is an autosomally inherited progressive disease with a Val30Met mutation, causing generalized sensory‐motor polyneuropathy. Quantitative sensory testing (QST) quantifies thermal threshold changes in patients with manifest general polyneuropathy, but its applicability at an early clinical stage of a strict biochemically defined disease has not yet been shown. Thermal QST was performed in 23 patients having a positive Val30Met marker and clinical symptoms of peripheral small‐fiber neuropathy but normal electrophysiological findings and compared to a reference group of 43 healthy volunteers, both subdivided into age groups ≤45 and >45 years. Significant differences between patients and controls were found at all test sites in both age groups, except for warm thresholds at the medial lower leg in those >45 years. QST thus demonstrated elevated thermal thresholds before the development of electrophysiological abnormalities, which indicate large‐fiber involvement. These findings confirm that QST is a useful method for documentation of developing polyneuropathy. Muscle Nerve, 2006</description><subject>Adult</subject><subject>Age Factors</subject><subject>Amyloid Neuropathies - complications</subject><subject>Amyloid Neuropathies - genetics</subject><subject>Amyloid Neuropathies/complications/genetics</subject><subject>amyloidosis</subject><subject>Biological and medical sciences</subject><subject>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methionine - genetics</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Peripheral Nerves - physiopathology</subject><subject>Prealbumin - genetics</subject><subject>QST</subject><subject>quantitative sensory testing</subject><subject>Sensory Thresholds - physiology</subject><subject>small-fiber neuropathy</subject><subject>Somatosensory Disorders - etiology</subject><subject>Somatosensory Disorders - genetics</subject><subject>Somatosensory Disorders/etiology/genetics</subject><subject>Temperature</subject><subject>thermal thresholds</subject><subject>transthyretin</subject><subject>Valine - genetics</subject><issn>0148-639X</issn><issn>1097-4598</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxS1ERZfCgS-AcqESEmnHju0kx2rLLkhtEX8K3CzHmRRDEgc7oeTb4zZLe0KcZqT5vRn7PUKeUTiiAOy4m8IRA1mUD8iKQpmnXJTFQ7ICyotUZuXXffI4hO8AQAuZPyL7NIeSQ1msiHk_6X60jcU6CdgH5-dEV73znW7taDEktk9Q-3ZOrrDH0Rrdxv4X-kUzet2H8dvs46hPdDe3ztbJ4Nq5x8m7QcfZE7LX6Dbg0109IJeb15_Wb9Kzd9u365Oz1AgJZWryCkFUGdC65pQKyZqSZcY0WrCsYBQilVW8obxmjWQosTGcogHBs6quWXZAXi17wzUOU6UGbzvtZ-W0Vaf284ly_kpN3aRo9Aoifrjgg3c_Jwyj6mww2La6RzcFFf3kIhfyvyAtBQOWFxF8uYDGuxA8NndPoKBuklIxKXWbVGSf75ZOVYf1PbmLJgIvdoAO0fQmGm1suOcKQeMnROSOF-7atjj_-6I6v_z493S6KGwY8fedQvsfSuZZLtSXi63abtYb_mFzrk6zP0uNvE0</recordid><startdate>200702</startdate><enddate>200702</enddate><creator>Heldestad, Victoria</creator><creator>Nordh, Erik</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D93</scope></search><sort><creationdate>200702</creationdate><title>Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy</title><author>Heldestad, Victoria ; Nordh, Erik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Amyloid Neuropathies - complications</topic><topic>Amyloid Neuropathies - genetics</topic><topic>Amyloid Neuropathies/complications/genetics</topic><topic>amyloidosis</topic><topic>Biological and medical sciences</topic><topic>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methionine - genetics</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Peripheral Nerves - physiopathology</topic><topic>Prealbumin - genetics</topic><topic>QST</topic><topic>quantitative sensory testing</topic><topic>Sensory Thresholds - physiology</topic><topic>small-fiber neuropathy</topic><topic>Somatosensory Disorders - etiology</topic><topic>Somatosensory Disorders - genetics</topic><topic>Somatosensory Disorders/etiology/genetics</topic><topic>Temperature</topic><topic>thermal thresholds</topic><topic>transthyretin</topic><topic>Valine - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heldestad, Victoria</creatorcontrib><creatorcontrib>Nordh, Erik</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Umeå universitet</collection><jtitle>Muscle & nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heldestad, Victoria</au><au>Nordh, Erik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy</atitle><jtitle>Muscle & nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2007-02</date><risdate>2007</risdate><volume>35</volume><issue>2</issue><spage>189</spage><epage>195</epage><pages>189-195</pages><issn>0148-639X</issn><issn>1097-4598</issn><eissn>1097-4598</eissn><coden>MUNEDE</coden><abstract>Transthyretin amyloid neuropathy of type 1 (Swedish–Portuguese type) is an autosomally inherited progressive disease with a Val30Met mutation, causing generalized sensory‐motor polyneuropathy. Quantitative sensory testing (QST) quantifies thermal threshold changes in patients with manifest general polyneuropathy, but its applicability at an early clinical stage of a strict biochemically defined disease has not yet been shown. Thermal QST was performed in 23 patients having a positive Val30Met marker and clinical symptoms of peripheral small‐fiber neuropathy but normal electrophysiological findings and compared to a reference group of 43 healthy volunteers, both subdivided into age groups ≤45 and >45 years. Significant differences between patients and controls were found at all test sites in both age groups, except for warm thresholds at the medial lower leg in those >45 years. QST thus demonstrated elevated thermal thresholds before the development of electrophysiological abnormalities, which indicate large‐fiber involvement. These findings confirm that QST is a useful method for documentation of developing polyneuropathy. Muscle Nerve, 2006</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17094098</pmid><doi>10.1002/mus.20689</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-639X |
ispartof | Muscle & nerve, 2007-02, Vol.35 (2), p.189-195 |
issn | 0148-639X 1097-4598 1097-4598 |
language | eng |
recordid | cdi_swepub_primary_oai_DiVA_org_umu_10680 |
source | Wiley |
subjects | Adult Age Factors Amyloid Neuropathies - complications Amyloid Neuropathies - genetics Amyloid Neuropathies/complications/genetics amyloidosis Biological and medical sciences Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction Diseases of striated muscles. Neuromuscular diseases Female Humans Male Medical sciences Methionine - genetics Nervous system (semeiology, syndromes) Neurology Peripheral Nerves - physiopathology Prealbumin - genetics QST quantitative sensory testing Sensory Thresholds - physiology small-fiber neuropathy Somatosensory Disorders - etiology Somatosensory Disorders - genetics Somatosensory Disorders/etiology/genetics Temperature thermal thresholds transthyretin Valine - genetics |
title | Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A34%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantified%20sensory%20abnormalities%20in%20early%20genetically%20verified%20transthyretin%20amyloid%20polyneuropathy&rft.jtitle=Muscle%20&%20nerve&rft.au=Heldestad,%20Victoria&rft.date=2007-02&rft.volume=35&rft.issue=2&rft.spage=189&rft.epage=195&rft.pages=189-195&rft.issn=0148-639X&rft.eissn=1097-4598&rft.coden=MUNEDE&rft_id=info:doi/10.1002/mus.20689&rft_dat=%3Cproquest_swepu%3E68945756%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5609-c7be05b301dd411562f923ccfa52382105603b4f14d2f62e6efc41ec0543bdd23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19520278&rft_id=info:pmid/17094098&rfr_iscdi=true |